Laman UtamaORCHPHARMA • NSE
add
Orchid Pharma Ltd
Tutup sebelumnya
₹1,436.95
Julat hari
₹1,421.35 - ₹1,479.55
Julat tahun
₹825.80 - ₹1,997.40
Permodalan pasaran
74.21B INR
Bilangan Purata
89.76K
Nisbah P/E
61.08
Hasil dividen
-
Pertukaran utama
NSE
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (INR) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | 2.23B | 12.05% |
Perbelanjaan pengendalian | 698.25J | 14.56% |
Pendapatan bersih | 272.36J | 37.53% |
Margin untung bersih | 12.23 | 22.79% |
Pendapatan bagi setiap syer | 5.37 | — |
EBITDA | 302.47J | 30.11% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (INR) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 2.44B | 384.25% |
Jumlah aset | 16.35B | 9.59% |
Jumlah liabiliti | 4.11B | 6.94% |
Jumlah ekuiti | 12.24B | — |
Syer tertunggak | 50.72J | — |
Harga kepada buku | 5.95 | — |
Pulangan pada aset | — | — |
Pulangan pada modal | 4.03% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (INR) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 272.36J | 37.53% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992. As of 2024, it was among the top fortune 500 Indian companies by market capitalization. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Diasaskan
1992
Tapak web
Pekerja
871
